Zaynich is developed by the Indian pharmaceutical company Wockhardt. Designed to combat multi-drug resistant (MDR) Gram-negative bacterial infections, which pose a significant threat to global public health. A patented combination of zidebactam + cefepime, engineered to cover major Gram-negative “superbugs” like …